<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">21892142</PMID>
      <DateCompleted>
        <Year>2011</Year>
        <Month>12</Month>
        <Day>07</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1476-4679</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2011</Year>
              <Month>Sep</Month>
              <Day>02</Day>
            </PubDate>
          </JournalIssue>
          <Title>Nature cell biology</Title>
          <ISOAbbreviation>Nat Cell Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The AMPK signalling pathway coordinates cell growth, autophagy and metabolism.</ArticleTitle>
        <Pagination>
          <StartPage>1016</StartPage>
          <EndPage>1023</EndPage>
          <MedlinePgn>1016-23</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/ncb2329</ELocationID>
        <Abstract>
          <AbstractText>One of the central regulators of cellular and organismal metabolism in eukaryotes is AMP-activated protein kinase (AMPK), which is activated when intracellular ATP production decreases. AMPK has critical roles in regulating growth and reprogramming metabolism, and has recently been connected to cellular processes such as autophagy and cell polarity. Here we review a number of recent breakthroughs in the mechanistic understanding of AMPK function, focusing on a number of newly identified downstream effectors of AMPK.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mihaylova</LastName>
            <ForeName>Maria M</ForeName>
            <Initials>MM</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular &amp; Cell Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shaw</LastName>
            <ForeName>Reuben J</ForeName>
            <Initials>RJ</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Acronym>HHMI</Acronym>
            <Agency>Howard Hughes Medical Institute</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P01 CA120964</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P01 CA120964-04</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK080425-04</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK080425</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>1P01CA120964</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2011</Year>
          <Month>09</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Nat Cell Biol</MedlineTA>
        <NlmUniqueID>100890575</NlmUniqueID>
        <ISSNLinking>1465-7392</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D021122">Protein Subunits</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.31</RegistryNumber>
          <NameOfSubstance UI="D055372">AMP-Activated Protein Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D055372" MajorTopicYN="N">AMP-Activated Protein Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016764" MajorTopicYN="N">Cell Polarity</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049109" MajorTopicYN="Y">Cell Proliferation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056890" MajorTopicYN="N">Eukaryota</DescriptorName>
          <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D021122" MajorTopicYN="N">Protein Subunits</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2011</Year>
          <Month>9</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2011</Year>
          <Month>9</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2011</Year>
          <Month>12</Month>
          <Day>13</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">21892142</ArticleId>
        <ArticleId IdType="mid">NIHMS341890</ArticleId>
        <ArticleId IdType="pmc">PMC3249400</ArticleId>
        <ArticleId IdType="doi">10.1038/ncb2329</ArticleId>
        <ArticleId IdType="pii">ncb2329</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Baena-Gonzalez E, Rolland F, Thevelein JM, Sheen J. A central integrator of transcription networks in plant stress and energy signalling. Nature. 2007;448:938–942.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17671505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hedbacker K, Carlson M. SNF1/AMPK pathways in yeast. Front Biosci. 2008;13:2408–2420.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2685184</ArticleId>
            <ArticleId IdType="pubmed">17981722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bokko PB, et al.  Diverse cytopathologies in mitochondrial disease are caused by AMP-activated protein kinase signaling. Mol Biol Cell. 2007;18:1874–1886.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1855013</ArticleId>
            <ArticleId IdType="pubmed">17332500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Narbonne P, Roy R. Caenorhabditis elegans dauers need LKB1/AMPK to ration lipid reserves and ensure long-term survival. Nature. 2009;457:210–214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19052547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson EC, et al.  Altered metabolism and persistent starvation behaviors caused by reduced AMPK function in Drosophila. PLoS One. 2010;5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2942814</ArticleId>
            <ArticleId IdType="pubmed">20862213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thelander M, Olsson T, Ronne H. Snf1-related protein kinase 1 is needed for growth in a normal day-night light cycle. Embo J. 2004;23:1900–1910.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC394236</ArticleId>
            <ArticleId IdType="pubmed">15057278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005;1:15–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16054041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardie DG, Carling D, Gamblin SJ. AMP-activated protein kinase: also regulated by ADP? Trends Biochem Sci. 2011</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21782450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao B, et al.  Structure of mammalian AMPK and its regulation by ADP. Nature. 2011;472:230–233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3078618</ArticleId>
            <ArticleId IdType="pubmed">21399626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oakhill JS, et al.  AMPK is a direct adenylate charge-regulated protein kinase. Science. 2011;332:1433–1435.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21680840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bland ML, Birnbaum MJ. Cell biology. ADaPting to energetic stress. Science. 2011;332:1387–1388.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21680830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hawley SA, et al.  Complexes between the LKB1 tumor suppressor, STRADalpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol. 2003;2:28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC333410</ArticleId>
            <ArticleId IdType="pubmed">14511394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woods A, et al.  LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol. 2003;13:2004–2008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14614828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shaw RJ, et al.  The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A. 2004;101:3329–3335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC373461</ArticleId>
            <ArticleId IdType="pubmed">14985505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer. 2009;9:563–575.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2756045</ArticleId>
            <ArticleId IdType="pubmed">19629071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hawley SA, et al.  Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005;2:9–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16054095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hurley RL, et al.  The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem. 2005;280:29060–29066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15980064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woods A, et al.  C(Ca2+)/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005;2:21–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16054096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fogarty S, et al.  Calmodulin-dependent protein kinase kinase-beta activates AMPK without forming a stable complex: synergistic effects of Ca2+ and AMP. Biochem J. 2010;426:109–118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2830670</ArticleId>
            <ArticleId IdType="pubmed">19958286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie M, et al.  A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc Natl Acad Sci U S A. 2006;103:17378–17383.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1859937</ArticleId>
            <ArticleId IdType="pubmed">17085580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herrero-Martin G, et al.  TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells. EMBO J. 2009;28:677–685.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2666037</ArticleId>
            <ArticleId IdType="pubmed">19197243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol. 2007;8:774–785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17712357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salt I, et al.  AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. Biochem J. 1998;334(Pt 1):177–187.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1219677</ArticleId>
            <ArticleId IdType="pubmed">9693118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lamia KA, et al.  AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation. Science. 2009;326:437–440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2819106</ArticleId>
            <ArticleId IdType="pubmed">19833968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oakhill JS, et al.  beta-Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK) Proc Natl Acad Sci U S A. 2010;107:19237–19241.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2984171</ArticleId>
            <ArticleId IdType="pubmed">20974912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki A, et al.  Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase. Mol Cell Biol. 2007;27:4317–4327.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1900064</ArticleId>
            <ArticleId IdType="pubmed">17420279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kodiha M, Rassi JG, Brown CM, Stochaj U. Localization of AMP kinase is regulated by stress, cell density, and signaling through the MEK--&gt;ERK1/2 pathway. Am J Physiol Cell Physiol. 2007;293:C1427–1436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17728396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kazgan N, Williams T, Forsberg LJ, Brenman JE. Identification of a nuclear export signal in the catalytic subunit of AMP-activated protein kinase. Mol Biol Cell. 2011;21:3433–3442.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2947478</ArticleId>
            <ArticleId IdType="pubmed">20685962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dorfman J, Macara IG. STRADalpha regulates LKB1 localization by blocking access to importin-alpha, and by association with Crm1 and exportin-7. Mol Biol Cell. 2008;19:1614–1626.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2291406</ArticleId>
            <ArticleId IdType="pubmed">18256292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sebbagh M, Santoni MJ, Hall B, Borg JP, Schwartz MA. Regulation of LKB1/STRAD localization and function by E-cadherin. Curr Biol. 2009;19:37–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2773019</ArticleId>
            <ArticleId IdType="pubmed">19110428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson KA, et al.  Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metab. 2008;7:377–388.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18460329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tamas P, et al.  Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes. J Exp Med. 2006;203:1665–1670.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2118355</ArticleId>
            <ArticleId IdType="pubmed">16818670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lizcano JM, et al.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. Embo J. 2004;23:833–843.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC381014</ArticleId>
            <ArticleId IdType="pubmed">14976552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alessi DR, Sakamoto K, Bayascas JR. Lkb1-dependent signaling pathways. Annu Rev Biochem. 2006;75:137–163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16756488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou G, et al.  Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108:1167–1174.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC209533</ArticleId>
            <ArticleId IdType="pubmed">11602624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shaw RJ, et al.  The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science. 2005;310:1642–1646.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3074427</ArticleId>
            <ArticleId IdType="pubmed">16308421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dykens JA, et al.  Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro. Toxicol Appl Pharmacol. 2008;233:203–210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18817800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hawley SA, et al.  Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab. 2010;11:554–565.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2935965</ArticleId>
            <ArticleId IdType="pubmed">20519126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardie DG. Neither LKB1 nor AMPK are the direct targets of metformin. Gastroenterology. 2006;131:973. author reply 974-975.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16952573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardie DG. AMP-Activated Protein Kinase as a Drug Target. Annu Rev Pharmacol Toxicol. 2007;47:185–210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16879084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rothbart SB, Racanelli AC, Moran RG. Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas. Cancer Res. 2010;70:10299–10309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3059241</ArticleId>
            <ArticleId IdType="pubmed">21159649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zang M, et al.  Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes. 2006;55:2180–2191.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16873680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baur JA, et al.  Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337–342.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4990206</ArticleId>
            <ArticleId IdType="pubmed">17086191</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pacholec M, et al.  SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem. 285:8340–8351.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2832984</ArticleId>
            <ArticleId IdType="pubmed">20061378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmidt C. GSK/Sirtris compounds dogged by assay artifacts. Nat Biotechnol. 2010;28:185–186.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20212464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Canto C, Auwerx J. AMP-activated protein kinase and its downstream transcriptional pathways. Cell Mol Life Sci. 2010</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3622821</ArticleId>
            <ArticleId IdType="pubmed">20640476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Um JH, et al.  AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes. 2010;59:554–563.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2828647</ArticleId>
            <ArticleId IdType="pubmed">19934007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hundal RS, et al.  Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes. 2000;49:2063–2069.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2995498</ArticleId>
            <ArticleId IdType="pubmed">11118008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zang M, et al.  AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol Chem. 2004;279:47898–47905.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15371448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foretz M, et al.  Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest. 2010;120:2355–2369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2898585</ArticleId>
            <ArticleId IdType="pubmed">20577053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Halseth AE, Ensor NJ, White TA, Ross SA, Gulve EA. Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations. Biochem Biophys Res Commun. 2002;294:798–805.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12061777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cool B, et al.  Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab. 2006;3:403–416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16753576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foretz M, et al.  Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes. 2005;54:1331–1339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15855317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang BB, Zhou G, Li C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 2009;9:407–416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19416711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gwinn DM, et al.  AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;30:214–226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2674027</ArticleId>
            <ArticleId IdType="pubmed">18439900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalender A, et al.  Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab. 2010;11:390–401.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3081779</ArticleId>
            <ArticleId IdType="pubmed">20444419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol. 2010;12:814–822.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3616322</ArticleId>
            <ArticleId IdType="pubmed">20811353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mizushima N, Levine B. Autophagy in mammalian development and differentiation. Nat Cell Biol. 2010;12:823–830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3127249</ArticleId>
            <ArticleId IdType="pubmed">20811354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamada Y, et al.  Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J Cell Biol. 2000;150:1507–1513.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2150712</ArticleId>
            <ArticleId IdType="pubmed">10995454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamada Y, et al.  Tor directly controls the Atg1 kinase complex to regulate autophagy. Mol Cell Biol. 2010;30:1049–1058.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2815578</ArticleId>
            <ArticleId IdType="pubmed">19995911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stephan JS, Yeh YY, Ramachandran V, Deminoff SJ, Herman PK. The Tor and PKA signaling pathways independently target the Atg1/Atg13 protein kinase complex to control autophagy. Proc Natl Acad Sci U S A. 2009;106:17049–17054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2761351</ArticleId>
            <ArticleId IdType="pubmed">19805182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mizushima N. The role of the Atg1/ULK1 complex in autophagy regulation. Curr Opin Cell Biol. 2010;22:132–139.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20056399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardie DG. AMPK and autophagy get connected. EMBO J. 2011;30:634–635.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3041958</ArticleId>
            <ArticleId IdType="pubmed">21326174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Behrends C, Sowa ME, Gygi SP, Harper JW. Network organization of the human autophagy system. Nature. 2010;466:68–76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2901998</ArticleId>
            <ArticleId IdType="pubmed">20562859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee JW, Park S, Takahashi Y, Wang HG. The association of AMPK with ULK1 regulates autophagy. PLoS One. 2010;5:e15394.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2972217</ArticleId>
            <ArticleId IdType="pubmed">21072212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Egan DF, et al.  Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science. 2011;331:456–461.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3030664</ArticleId>
            <ArticleId IdType="pubmed">21205641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13:132–141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3987946</ArticleId>
            <ArticleId IdType="pubmed">21258367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Wilson WA, Fujino MA, Roach PJ. Antagonistic controls of autophagy and glycogen accumulation by Snf1p, the yeast homolog of AMP-activated protein kinase, and the cyclin-dependent kinase Pho85p. Mol Cell Biol. 2001;21:5742–5752.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC87294</ArticleId>
            <ArticleId IdType="pubmed">11486014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shang L, et al.  Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK. Proc Natl Acad Sci U S A. 2011;108:4788–4793.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3064373</ArticleId>
            <ArticleId IdType="pubmed">21383122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakada D, Saunders TL, Morrison SJ. Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature. 2010;468:653–658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3059717</ArticleId>
            <ArticleId IdType="pubmed">21124450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones RG, et al.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell. 2005;18:283–293.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15866171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang J, et al.  The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol. 2007;9:218–224.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17237771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bjorklund MA, et al.  Non-CDK-bound p27 (p27(NCDK)) is a marker for cell stress and is regulated through the Akt/PKB and AMPK-kinase pathways. Exp Cell Res. 2010;316:762–774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20036235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zagorska A, et al.  New roles for the LKB1-NUAK pathway in controlling myosin phosphatase complexes and cell adhesion. Sci Signal. 2010;3:ra25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20354225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carling D, Zammit VA, Hardie DG. A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis. FEBS Lett. 1987;223:217–222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2889619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sato R, Goldstein JL, Brown MS. Replacement of serine-871 of hamster 3-hydroxy-3-methylglutaryl-CoA reductase prevents phosphorylation by AMP-activated kinase and blocks inhibition of sterol synthesis induced by ATP depletion. Proc Natl Acad Sci U S A. 1993;90:9261–9265.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC47547</ArticleId>
            <ArticleId IdType="pubmed">8415689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakamoto K, Holman GD. Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic. Am J Physiol Endocrinol Metab. 2008;295:E29–37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2493596</ArticleId>
            <ArticleId IdType="pubmed">18477703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watt MJ, et al.  Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am J Physiol Endocrinol Metab. 2006;290:E500–508.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16188906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahmadian M, et al.  Desnutrin/ATGL Is Regulated by AMPK and Is Required for a Brown Adipose Phenotype. Cell Metab. 2011;13:739–748.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3148136</ArticleId>
            <ArticleId IdType="pubmed">21641555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Das SK, et al.  Adipose triglyceride lipase contributes to cancer-associated cachexia. Science. 2011;333:233–238.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21680814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bungard D, et al.  Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation. Science. 2010;329:1201–1205.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3922052</ArticleId>
            <ArticleId IdType="pubmed">20647423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zaugg K, et al.  Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes Dev. 2011;25:1041–1051.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3093120</ArticleId>
            <ArticleId IdType="pubmed">21576264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardie DG. Transcription. Targeting the core of transcription. Science. 2010;329:1158–1159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20813944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bass J, Takahashi JS. Circadian integration of metabolism and energetics. Science. 2010;330:1349–1354.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3756146</ArticleId>
            <ArticleId IdType="pubmed">21127246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Um JH, et al.  Activation of 5′-AMP-activated kinase with diabetes drug metformin induces casein kinase Iepsilon (CKIepsilon)-dependent degradation of clock protein mPer2. J Biol Chem. 2007;282:20794–20798.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17525164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Um JH, et al.  AMPK Regulates Circadian Rhythms in a Tissue- and Isoform-Specific Manner. PLoS One. 2011;6:e18450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3069094</ArticleId>
            <ArticleId IdType="pubmed">21483791</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y, et al.  AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice. Cell Metab. 2011;13:376–388.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3086578</ArticleId>
            <ArticleId IdType="pubmed">21459323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Porstmann T, et al.  SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 2008;8:224–236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2593919</ArticleId>
            <ArticleId IdType="pubmed">18762023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawaguchi T, Osatomi K, Yamashita H, Kabashima T, Uyeda K. Mechanism for fatty acid “sparing” effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J Biol Chem. 2002;277:3829–3835.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11724780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dentin R, Girard J, Postic C. Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie. 2005;87:81–86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15733741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bricambert J, et al.  Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J Clin Invest. 2010;120:4316–4331.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2993582</ArticleId>
            <ArticleId IdType="pubmed">21084751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tong X, Zhao F, Mancuso A, Gruber JJ, Thompson CB. The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation. Proc Natl Acad Sci U S A. 2009;106:21660–21665.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2799883</ArticleId>
            <ArticleId IdType="pubmed">19995986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Altarejos JY, Montminy M. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol. 2011;12:141–151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4324555</ArticleId>
            <ArticleId IdType="pubmed">21346730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mair W, et al.  Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB. Nature. 2011;470:404–408.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3098900</ArticleId>
            <ArticleId IdType="pubmed">21331044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hong YH, Varanasi US, Yang W, Leff T. AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J Biol Chem. 2003;278:27495–27501.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12740371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim E, et al.  Metformin Inhibits Nuclear Receptor TR4-Mediated Hepatic Stearoyl-Coenzyme A Desaturase 1 Gene Expression With Altered Insulin Sensitivity. Diabetes. 2011 doi: 10.2337/db10-0393.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db10-0393</ArticleId>
            <ArticleId IdType="pmc">PMC3292323</ArticleId>
            <ArticleId IdType="pubmed">21478464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jager S, Handschin C, St-Pierre J, Spiegelman BM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A. 2007;104:12017–12022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1924552</ArticleId>
            <ArticleId IdType="pubmed">17609368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inoue E, Yamauchi J. AMP-activated protein kinase regulates PEPCK gene expression by direct phosphorylation of a novel zinc finger transcription factor. Biochem Biophys Res Commun. 2006;351:793–799.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17097062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van der Linden AM, Nolan KM, Sengupta P. KIN-29 SIK regulates chemoreceptor gene expression via an MEF2 transcription factor and a class II HDAC. EMBO J. 2007;26:358–370.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1783467</ArticleId>
            <ArticleId IdType="pubmed">17170704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang S, Bezprozvannaya S, Li S, Olson EN. An expression screen reveals modulators of class II histone deacetylase phosphorylation. Proc Natl Acad Sci U S A. 2005;102:8120–8125.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1149448</ArticleId>
            <ArticleId IdType="pubmed">15923258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dequiedt F, et al.  New role for hPar-1 kinases EMK and C-TAK1 in regulating localization and activity of class IIa histone deacetylases. Mol Cell Biol. 2006;26:7086–7102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1592903</ArticleId>
            <ArticleId IdType="pubmed">16980613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berdeaux R, et al.  SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes. Nat Med. 2007;13:597–603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17468767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGee SL, et al.  AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes. 2008;57:860–867.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18184930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mihaylova MM, et al.  Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis. Cell. 2011;145:607–621.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3117637</ArticleId>
            <ArticleId IdType="pubmed">21565617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang B, et al.  A hormone-dependent module regulating energy balance. Cell. 2011;145:596–606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3129781</ArticleId>
            <ArticleId IdType="pubmed">21565616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet. 2009;10:32–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3215088</ArticleId>
            <ArticleId IdType="pubmed">19065135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greer EL, et al.  The Energy Sensor AMP-activated Protein Kinase Directly Regulates the Mammalian FOXO3 Transcription Factor. J Biol Chem. 2007;282:30107–30119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17711846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greer EL, et al.  An AMPK-FOXO Pathway Mediates Longevity Induced by a Novel Method of Dietary Restriction in C. elegans. Curr Biol. 2007;17:1646–1656.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2185793</ArticleId>
            <ArticleId IdType="pubmed">17900900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Canto C, et al.  AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 2009;458:1056–1060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3616311</ArticleId>
            <ArticleId IdType="pubmed">19262508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Canto C, et al.  Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 2010;11:213–219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3616265</ArticleId>
            <ArticleId IdType="pubmed">20197054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Narkar VA, et al.  AMPK and PPARdelta agonists are exercise mimetics. Cell. 2008;134:405–415.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2706130</ArticleId>
            <ArticleId IdType="pubmed">18674809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lagouge M, et al.  Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006;127:1109–1122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17112576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mirouse V, Billaud M. The LKB1/AMPK polarity pathway. FEBS Lett. 2011;585:981–985.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21185289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watts JL, Morton DG, Bestman J, Kemphues KJ. The C. elegans par-4 gene encodes a putative serine-threonine kinase required for establishing embryonic asymmetry. Development. 2000;127:1467–1475.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10704392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin SG, St Johnston D. A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity. Nature. 2003;421:379–384.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12540903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baas AF, et al.  Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. Cell. 2004;116:457–466.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15016379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jansen M, Ten Klooster JP, Offerhaus GJ, Clevers H. LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism. Physiol Rev. 2009;89:777–798.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19584313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee JH, et al.  Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature. 2007;447:1017–1020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17486097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mirouse V, Swick LL, Kazgan N, St Johnston D, Brenman JE. LKB1 and AMPK maintain epithelial cell polarity under energetic stress. J Cell Biol. 2007;177:387–392.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2064817</ArticleId>
            <ArticleId IdType="pubmed">17470638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Li J, Young LH, Caplan MJ. AMP-activated protein kinase regulates the assembly of epithelial tight junctions. Proc Natl Acad Sci U S A. 2006;103:17272–17277.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1859922</ArticleId>
            <ArticleId IdType="pubmed">17088526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng B, Cantley LC. Regulation of epithelial tight junction assembly and disassembly by AMP-activated protein kinase. Proc Natl Acad Sci U S A. 2007;104:819–822.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1783397</ArticleId>
            <ArticleId IdType="pubmed">17204563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, et al.  AMPK activation and GSK-3{beta} inhibition induce Ca2+ independent deposition of tight junction components at the plasma membrane. J Biol Chem. 2011 doi: 10.1074/jbc.M110.186932.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M110.186932</ArticleId>
            <ArticleId IdType="pmc">PMC3089531</ArticleId>
            <ArticleId IdType="pubmed">21383016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyamoto T, et al.  AMP-activated protein kinase phosphorylates Golgi-specific brefeldin A resistance factor 1 at Thr1337 to induce disassembly of Golgi apparatus. J Biol Chem. 2008;283:4430–4438.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18063581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakano A, et al.  AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation. Nat Cell Biol. 2010;12:583–590.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20495555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi JH, et al.  The FKBP12-rapamycin-associated protein (FRAP) is a CLIP-170 kinase. EMBO Rep. 2002;3:988–994.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1307618</ArticleId>
            <ArticleId IdType="pubmed">12231510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boehlke C, et al.  Primary cilia regulate mTORC1 activity and cell size through Lkb1. Nat Cell Biol. 2010;12:1115–1122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3390256</ArticleId>
            <ArticleId IdType="pubmed">20972424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams T, Courchet J, Viollet B, Brenman JE, Polleux F. AMP-activated protein kinase (AMPK) activity is not required for neuronal development but regulates axogenesis during metabolic stress. Proc Natl Acad Sci U S A. 2011;108:5849–5854.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3078367</ArticleId>
            <ArticleId IdType="pubmed">21436046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drewes G, Ebneth A, Preuss U, Mandelkow EM, Mandelkow E. MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell. 1997;89:297–308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9108484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishimura I, Yang Y, Lu B. PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. Cell. 2004;116:671–682.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15006350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thornton C, Bright NJ, Sastre M, Muckett PJ, Carling D. AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid beta-peptide exposure. Biochem J. 2011;434:503–512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21204788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amato S, et al.  AMP-activated protein kinase regulates neuronal polarization by interfering with PI 3-kinase localization. Science. 2011;332:247–251.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3325765</ArticleId>
            <ArticleId IdType="pubmed">21436401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McDonald A, et al.  Control of insulin granule dynamics by AMPK dependent KLC1 phosphorylation. Islets. 2009;1:198–209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21099273</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
